ClinicalTrials.Veeva

Menu

3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer (TREE PRO)

Seoul National University logo

Seoul National University

Status

Not yet enrolling

Conditions

Endometrial Cancer

Treatments

Procedure: no lymph node dissection

Study type

Observational

Funder types

Other

Identifiers

NCT04227249
KGOG 3021

Details and patient eligibility

About

To verify the safety of omission of lymph node dissection in ultra-low-risk endometrial cancer (KGOG criteria), we examine the survival of women with ultra-low-risk endometrial cancer who do not undergo lymph node dissection

Enrollment

153 estimated patients

Sex

Female

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • endometrioid type
  • anticipated surgery omitting lymph node dissection for endometrial cancer
  • pelvis MRI, CA125 - satisfying KGOG criteria
  • no distant metastasis
  • age 19 or more

Exclusion criteria

  • other cancer within 5 yr
  • previous hysterectomy
  • previous therapy for endometrial cancer

Trial design

153 participants in 1 patient group

Experimental
Description:
women who do not undergo lymph node dissection
Treatment:
Procedure: no lymph node dissection

Trial contacts and locations

0

Loading...

Central trial contact

kidong kim, md

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems